Clinical Trials
16 trialsNCT07579286 2026-05-12
LumiNOde
N.N. Petrov National Medical Research Center of Oncology
Phase NA Recruiting
NCT04333537 2026-05-04
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
NRG Oncology
Phase 2/3 Recruiting
NCT07508306 2026-04-02
Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity
Faculty of Medicine of Tunis
Recruiting
NCT06381154 2026-01-30
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
Mayo Clinic
Phase 2 Recruiting
NCT04959474 2026-01-23
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
Thomas Jefferson University
Phase NA Recruiting
NCT07146295 2026-01-12
INFINITE
St. Antonius Hospital
Phase NA Recruiting
NCT07121595 2025-08-13
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
University of Michigan Rogel Cancer Center
Phase 2 Recruiting
NCT05774483 2025-07-17
SECOND N0
Tata Memorial Hospital
Phase NA Recruiting
NCT03719547 2025-07-01
RACC
Karolinska Institutet
Phase NA Recruiting
NCT05108090 2025-06-11
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
Indiana University
Phase NA Recruiting
NCT05927818 2024-11-25
Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer
Istanbul University
Phase NA Recruiting
NCT06666634 2024-10-30
NANOSCAN
The Netherlands Cancer Institute
Phase NA Recruiting
NCT06619002 2024-10-02
LYSE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT05797415 2024-10-01
BLS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT06121570 2023-11-08
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1 Recruiting
NCT05981014 2023-08-08
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2 Recruiting